# Lakefront Biotherapeutics NV (LKFT.AS): MoatMap facts

As of 3 Nov 2026. Research data, not investment advice.

As of 3 Nov 2026, MoatMap's StockRank for Lakefront Biotherapeutics NV (LKFT.AS) is 98/100, ranked against 24,000+ stocks in 35 markets (Quality 73, Value 85, Momentum 57, each scored against its sector).

- StockRank: 98/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 73, Value 85, Momentum 57: each a 0-100 percentile within Healthcare.
- Position: #489 overall, #47 in Healthcare.
- Listing: Netherlands, AMS; Healthcare / Biotechnology.
- Last close: 28.44 EUR on 2 Nov 2026.
- Insider filings, last 180 days: no director or 5%+ holder trades with a stated value.

Source: https://moatmap.ai/stock/LKFT.AS
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker